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Background and Objectives Red blood cells (RBCs) suffer from lesions during
cold storage, depending in part on their ability to counterbalance oxidative stress
by activating their antioxidant defence. The aim of this study was to monitor the
antioxidant power (AOP) in erythrocyte concentrates (ECs) during cold storage.
Materials and Methods Six ECs were prepared in saline-adenine-glucose-manni-
tol (SAGM) additive solution and followed during 43 days. The AOP was quanti-
fied electrochemically using disposable electrode strips and compared with
results obtained from a colorimetric assay. Haematological data, data on haemol-
ysis and the extracellular concentration of uric acid were also recorded. Addi-
tionally, a kinetic model was developed to extract quantitative kinetic data on
the AOP behaviour.
Results The AOP of total ECs and their extracellular samples attained a maxi-
mum after 1 week of storage prior to decaying and reaching a plateau, as shown
by the electrochemical measurements. The observed trend was confirmed with a
colorimetric assay. Uric acid had a major contribution to the extracellular AOP.
Interestingly, the AOP and uric acid levels were linked to the sex of the donors.
Conclusion The marked increase in AOP during the first week of storage suggests
that RBCs are impacted early by the modification of their environment. The AOP
behaviour reflects the changes in metabolism activity following the adjustment
of the extracellular uric acid level. Knowing the origin, interdonor variability and
the effects of the AOP on the RBCs could be beneficial for the storage quality,
which will have to be further studied.
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Introduction
The storage of red blood cells (RBCs) under blood-bank-
ing conditions causes lesions that affect the quality of the
product [1]. Recent clinical trials suggest that transfusing
short-term stored erythrocyte concentrates (ECs) does not
provide advantages compared to the transfusion of older
ECs [2–4], although some reports describe deleterious
effects in transfusion patients due to these age alterations
[5–7]. Storage lesions [1, 8] may be either reversible and
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per se reversed by transfusion, such as the decrease in
metabolism and protein activity [9–12], or irreversible,
affecting protein integrity, phenotype and morphological
properties of RBCs [13–15].
Oxidative stress is closely associated with these lesions
[15–17] and the antioxidant (AO) defence system, which
controls oxidation, plays an important preventive role.
Likewise, an impaired AO defence induces a cascade of
events related to protein function impairment, proteasome
inhibition, oxidized protein accumulation at the RBC
membrane and their elimination through microvesicula-
tion [12, 18, 19]. The microvesicles released during stor-
age [20, 21] could contribute to deleterious transfusion
effects linked to haemostasis [22, 23]. The quality of RBCs
following storage also depends on the donor’s character-
istics [24–26], including AO content, as a higher level of
uric acid (UA, a major AO in plasma) contributes to the
storability of RBCs [27].
Several approaches can be used for measuring the
global AO activity in biological fluids, including spec-
trophotometric, fluorescence and electrochemical methods
[28–31]. The electrochemical approach shows several
advantages over the other methodologies. For instance,
sample pretreatments are not required and measurements
can be performed immediately after the electrochemical
cell is loaded with the sample [32, 33]. Moreover, electro-
chemical measurements are not affected by background
colours or autofluorescence, as occurs in most optical
detection methods. In one electrochemical method, the
current generated by the electrochemical oxidation of AOs
dissolved in a liquid sample is measured. This process is
based on the transfer of one or more electrons from the AO
molecules to the biased working electrode (WE) of an elec-
trochemical sensor (Fig. 1). The recorded current is propor-
tional to the AO concentration. Each redox-active AO
species is characterized by a different redox potential.
Therefore, a linear potential ramp is applied to detect the
full range of AOs in the sample. Such measurements might
include the electrochemical detection of additional com-
pounds in the sample which are also electrochemically
active, but which do not show any relevant AO activity.
Nevertheless, by their nature, most AO species, especially
the ones of high biological importance, are electrochemi-
cally converted at low redox potentials with a high rate.
Therefore, it is possible to distinguish the relevant AO sig-
nals from the signals not related to AOs using a mathemat-
ical treatment of the recorded curves which suppresses the
measured signals at higher potentials. This procedure was
introduced as electrochemical pseudo-titration voltamme-
try (vide infra) [32, 34].
Whereas the consequences of oxidative stress are well
documented [1, 15–17, 35], the global AO content has
been poorly quantified during RBC storage. We followed
the global AO content of ECs and extracellular samples
utilizing an electrochemical method. The measurement
period started 1 day after blood donation and ended at
day 43 (1 day after the expiration date for transfusion).
Several trends which have not been reported elsewhere,
such as an increase in the AO content in the EC and
extracellular samples during the first days of storage, are
presented and discussed.
Materials and methods
Preparation of the erythrocyte concentrates and
samples
Six healthy donors (three women and three men) gave
whole blood under signed consent at the blood centre of
the Transfusion Interregionale CRS, Epalinges, Switzer-
land [donor’s characteristics are specified in supporting
information (Table SI-1)]. ECs were prepared using a top/
bottom processing method. Whole blood (450 – 50 ml)
was collected in 63 ml of citrate-phosphate-dextrose anti-
coagulant (Fresenius Kabi, CQ32250, Germany). After a
holding time (between 25 and 425 h, depending of the
donation) at a temperature of 22 – 2°C, the bags were
centrifuged (5047 g for 13 min at 22°C on a Roto Silenta
630 RS, Hettich, Switzerland) to separate blood compo-
nents, and a semi-automated pressure was applied to dis-
tribute the fractions into sterile interconnected bags.
Finally, the RBCs were filtered to remove residual
leucocytes and were stored at 4°C in 100 ml of saline-
adenine-glucose-mannitol (SAGM) additive solution at a
haematocrit of 566 – 16%.
EC samples (3 ml per bag) were collected daily from
day 1 to 10, then weekly until day 43. Global AO power
(AOP) and haematological data were measured on total
ECs. Supernatants were separated from RBCs by centrifu-
gation (2000 g for 10 min at 4°C) and used for extracel-
lular AOP and haemolysis measurements. The remaining
supernatants were saved at -80°C until quantification of
the extracellular UA concentrations.
Haematological data and haemolysis
measurements
Haematological data, such as the haematocrit (HCT) and
the haemoglobin (Hb) concentration, were recorded with
an automated haematology analyser (KX-21N, Sysmex,
Switzerland). The concentration of Hb in the supernatant
was determined according to the Harboe method with the
3-point ‘Allen correction’ by measuring the absorbance at
415, 380 and 450 nm with a spectrophotometer (Nano-
Drop 2000c, Thermo Scientific) [36, 37]. The percentage
of haemolysis was then calculated using Eqn 1
© 2017 International Society of Blood Transfusion
Vox Sanguinis (2017) 112, 638–647
Antioxidant capacity in erythrocyte concentrate 639
Haemolysis ¼ Hb supernatant  1 HCTð Þ
Hb total
 100 ð1Þ
where Hb supernatant is the concentration of Hb in the
supernatant and Hb total is the concentration of Hb in
the entire sample, both in g/l.
Colorimetric antioxidant power measurement
The extracellular AOP was quantified using a colorimet-
ric method based on the decolourization of the green
2,2’-azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid)
radical cation (ABTS+), which converts into colourless
ABTS by reduction with AOs. The bleaching rate is pro-
portional to the AO concentration. Briefly, 80 ll of sam-
ple were mixed in a cuvette with 800 ll of acetate
buffer (04 mM, pH 58) and 40 ll of ABTS+ in acetate
buffer (30 mM, pH 36), according to Erel’s protocol
[38], with slight modifications. The absorbance was mea-
sured (in duplicate) at 660 nm with a NanoDrop spec-
trophotometer. The assay was calibrated using ascorbic
acid as a standard.
Uric acid quantification
One hundred and fifty ll of supernatants were transferred
in Vivaspin 500 columns (Sartorius, G€ottingen, Germany)
and centrifuged at 15 000 g for 30 min at 4°C. Then,
30 ll of filtrates were dried (Genevac EZ-2 Mk3, Genevac
Ltd, Ipswich, England) for 45 min and stored at -28°C.
Just before analysis, the dried samples were dissolved in
90 ll of 45/55 (v/v) ammonium acetate (100 mM, pH8)/
acetonitrile, vortexed, sonicated for 10 min at room tem-
perature and stored on ice for 20 min. After a final cen-
trifugation at 20 800 g for 30 min at 4°C, 45 ll of the
supernatants were transferred into an injection vial.
One microlitre of sample was injected in duplicate on a
high pressure liquid chromatography (HPLC) apparatus
(Dionex UltiMate 3000 RSLCnano System, Thermo Scien-
tific, Rockford, IL, USA). The capillary column (ZIC-HILIC,
150 9 03 mm, 5 ll, SeQuant Merck, Germany) was kept
at 40°C. The chromatography conditions are summarized
in Table SI-2 (solvent A was 100 mM ammonium acetate
at pH 8 and solvent B 100% acetonitrile).
UA detection was performed by measuring its specific
UV signal at 292 nm. Peak integration was calculated
using the HyStar postprocessing software (Bruker Dalton-
ics, Bremen, Germany). The nature of the detected com-
pound was confirmed by mass spectrometry (Bruker
Daltonics, amaZon ETD, negative ionization mode). Cali-
bration was done for UA concentrations ranging between
0 and 750 lM (Fig. SI-1). The UA standard was dissolved
in SAGM and prepared for injection in the same way as
the samples.
Electrochemical antioxidant power measurement
Electrodes
Screen-printed electrode strips comprising a carbon paste
WE, a Ag/AgCl quasi-reference electrode (QRE) and a car-
bon paste counter electrode (CE) were provided by EDEL-
for-Life (Switzerland). The electrode areas (i.e. 1 mm 9
1 mm for WE, CE and QRE) were defined precisely by a
screen-printed dielectric insulation layer. On top of
these electrode patterns, a spacer layer and a cover lid
with two small openings on both sides of the sensor
structure were created, forming a capillary. Hence, a thin,
electrochemical cell is created, which is filled with the
liquid sample by capillary forces within a fraction of sec-
ond. This process leads to a reproducible electrode–sample
interface.
Electrochemical apparatus, linear sweep voltamme-
try and electrochemical pseudo-titration voltamme-
try
Electrochemical measurements were performed at least in
duplicate using an Edelmeter potentiostat (EDEL-for-Life,
Switzerland). For each measurement, a fresh electrode
strip was used and the electrochemical cell was filled with
~3 ll of total or extracellular EC sample. Three seconds
after loading, linear sweep voltammograms (LSVs) were
Fig. 1 Illustration of the electrochemical measurements of AOs using the
3-electrode disposable strips.
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recorded from 0 V to 12 V with a scan rate of 100 mV/s.
All potentials herein are reported with respect to the inte-
grated Ag/AgCl QRE. The electrode strip design allowed a
rapid measurement, avoiding long exposure times of the
samples to air and to the electrode surfaces.
Each LSV was transformed from a current value in
ampere to an AOP in nW using the electrochemical
pseudo-titration voltammetry [32, 34]. In brief, a Fermi-
Dirac function was developed that contained curve points
of unity at low potentials that became zero at higher
potentials (Fig. SI-2). The measured current vs. potential
curves, which start at zero current and that increase at
higher potentials due to the presence of AOs, were multi-
plied by the Fermi-Dirac function resulting in a
peak-curved shape. The AOP was then calculated by the
integration of the obtained curves and represented a
quantitative value to (1) compare the AOP of different
samples and (2) to follow the AOP of each sample over
time (Fig. SI-3).
Results
The six ECs exhibited standard haematological values
over the storage period (Table SI-3), that is a slight
decrease in RBC concentration and an increase in RBC
size [14]. Haemolysis at the end of the storage period
reached 018, 019, 020, 029, 025 and 021% for EC 1
to 6, respectively, which remained below the generally
recommended value of 08%.
The calculated AOPs of the extracellular samples are
plotted in Fig. 2a. All six samples exhibited a steep
increase in the AOP during the first week of storage fol-
lowed by a decrease until a plateau was reached. The
extracellular AOP was linearly correlated with the AOP
of the total EC (Fig. 3a). AOP levels in the six ECs were
related to the sex of the donor. Indeed, the AOP was
generally lower in women and remained lower during
the storage compared to men (the integrated extracellu-
lar AOP was 5063 – 349 daynW for women and 6547
– 668 daynW for men, P-value = 0027). Note that
measurements in the bare storage solution (i.e. SAGM
only) as a blank showed very low currents and demon-
strated that all recorded signals in extracellular and EC
samples were in majority due to the presence of soluble
AOs coming from the residual plasma and RBCs
(Fig. SI-4).
To quantitatively describe the observed trends, a kinetic
model has been developed based on the following
reactions:
AOpre k1! AO k2! AOox ð2Þ
where AOpre stands for precursors of AOs and AOox for
the oxidized AOs. k1 and k2 are kinetic constants that
represent the production and the consumption of AOs,
respectively.
The AOP as a function of time is thus expressed con-
sidering 1st-order reactions as follows (SI-6 for details):
AOP tð Þ ¼ AOP0ek2t þ k1
k2  k1 AOPpre;0 e
k1t  ek2t 
þ AOPpre;const k1
k2
ð3Þ
where AOP0 and AOPpre,0 are the AOPs at day 0 given in
nW.
The measured AOPs were fitted to the equation derived
from the kinetic model (Fig. 2b). The values obtained
from the fitting procedure are shown in Table 1. Kinetic
constant k2 was lower than k1, which is supported by the
slow decay observed during storage. The efflux phase
represented by k1 was on average higher in women, and
the second phase (slower and represented by k2) was
independent from the donor’s sex.
The UA molecules significantly contribute to the AO
defences of ECs. As a consequence, the UA concentration
increased similarly to the AOP during the first week of
storage (Fig. 4), reaching a maximum after 5 days for
women and 7 days for men (maximum UA of 1006 –
226 lM for women and 1471 – 138 lM for men,
P-value = 0038). Men exhibited a higher UA concentra-
tion during the whole storage (area under the curve of
2687 – 416 dayslM for women and 4231 – 541 dayslM
for men, P-value = 0017). A plateau was reached after
approximately 3 weeks for samples from women and
4 weeks for samples from men. The extracellular UA con-
centration and AOP were strongly positively correlated in
a linear model (R2 = 094, Fig. 3b).
The trends observed for the AOP measured with the
electrochemical method and colorimetric assay (Fig. 5)
were similar for both the early-storage trends and sex-
related differences. However, a slight increase, instead of
a plateau, was observed for the AOP in the measure-
ments using the colorimetric assay at the end of storage.
One hypothesis is that lipophilic AOs stemming from
aged RBCs at the end of the storage were detected spec-
trophotometrically but not electrochemically due to their
low electrochemical activity. It should be noted that a
Hb concentration up to a level of 31 lM (i.e. 04%
haemolysis) does not influence the electrochemical assay
(Fig. SI-4) and that the colorimetric assay was corrected
for Hb.
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Discussion
RBCs possess enzymatic (such as superoxide dismutase,
catalase and peroxiredoxin) and non-enzymatic defences
(UA, ascorbic acid, glutathione, etc.) that control reactive
oxygen species, limit oxidative damage [18] and maintain
a low level of metHb (a product of Hb autooxidation)
[39]. The AOP measured in ECs was closely correlated to
the extracellular concentration of UA, which is a known
endogenous AO [40, 41], shown to account for 60-70% of
the AOP in ECs [42].
The results obtained with the electrochemical and col-
orimetric AOP measurements suggest that the AO capacity
of the investigated ECs is donor-dependent and impacted
by changes in the RBC environment because of the blood
processing. Of note, the type of additive solution used
with variable composition, osmolarity and pH can impact
differently the RBCs [43, 44]. Variations of the AOP
0
50
100
150
200
Time(days)
A
O
P(
nW
)
EC 1
0
50
100
150
200
A
O
P(
nW
)
EC 2
0
50
100
150
200
A
O
P(
nW
)
EC 3
0 10 20 30 40
80
120
160
200
240
Time(days)
A
O
P e
xt
(n
W
)
EC 1
EC 2
EC 3
EC 4
Women
Men
EC 5
EC 6
0
50
100
150
200
A
O
P(
nW
)
EC 4
0
50
100
150
200
A
O
P(
nW
)
EC 5
0 10 20 30 40
Time(days)
0 10 20 30 40
Time(days)
0 10 20 30 40
Time(days)
0 10 20 30 40
Time(days)
0 10 20 30 40
Time(days)
0 10 20 30 40
0
50
100
150
200
A
O
P(
nW
)
EC 6
(a)
(b)
Fig. 2 Extracellular AOP (AOPext) measured
with the Edelmeter for EC 1 to 6 over 43 days.
(a) Extracellular AOP with individual and mean
values (dotted line). (b) Extracellular AOP for
individual ECs with curve ﬁts for the kinetic
model (dashed lines). Each measure was taken
in duplicate or triplicate; error bars represent
the SD.
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values correspond to metabolic activity [10, 11] and are
visible earlier compared to other ageing makers (i.e.
haemolysis and microvesiculation, lactate accumulation,
changes of morphology, etc.), which only become signifi-
cantly visible after several weeks of storage [1, 8, 19].
The increase in AOP during the first week might result
from a boost in RBC metabolism, as shown by the
increased intracellular adenosine triphosphate (ATP) con-
centration during the first 10 days of RBC storage [9, 10].
Most probably, the evolution of AOP and UA concentra-
tion observed during the first week of storage is largely
governed by an equilibration process between intracellu-
lar and extracellular media. Indeed, the residual plasma is
diluted in the ECs because of the addition of SAGM to
the RBCs. This is suggested by the steep increase in extra-
cellular UA and the decrease in intracellular UA observed
by Bordbar et al. [10]. In theory, the calculated dilution
factor of plasma in the ECs is 11, even though an accu-
rate measurement of the exact residual concentration
needs to be standardized. Indeed, it is subject to strong
variations (e.g. because of different blood processing
methods), as pointed out by Jordan and Acker [45]. The
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Fig. 3 (a) Correlation between total (AOPtot)
and extracellular AOP (AOPext) measured with
the Edelmeter, and (b) between extracellular
AOP and UA (UAext) concentration. Each point
represents the mean value for six ECs at a
different time. The linear correlation was
calculated (R2 regression coefﬁcient).
Table 1 Fitting parameters for the extracellular AOPs
Women Men
EC 1 EC 2 EC 3 EC 4 EC 5 EC 6
AOP0 (nW) -49153 -31623 -47338 -64209 -29940 -27713
AOPpre,0 (nW) 96726 66094 136954 203419 84982 164583
AOPpre,const (nW) 25732 9086 110585 149710 56649 120130
k1 (per days) 0955 0495 0279 0191 0356 0157
k2 (per days) 0199 0044 0279 0191 0134 0157
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Fig. 4 Extracellular UA (UAext) concentration
measured by HPLC. Samples were injected in
duplicate; error bars represent – the SD. The
mean extracellular UA concentration was
calculated for women and men (dotted lines).
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extracellular UA concentration, normally between 120
and 450 lM in human plasma, is subsequently diluted by
the same factor. The dynamic of the UA concentration is
governed by the active or passive transport of UA
through the RBC membrane. Active UA transport is prob-
ably ATP-dependent [46] and membrane permeability for
UA increases with storage time [47]. The balance between
the intracellular and extracellular UA concentration was
reached during the first week of storage. Interestingly, the
increase in plasma AO activity was not observed during
whole-blood storage (CPDA-1), where the analysis was
based on a total radical-trapping AO parameter [48]. It
corroborates our hypothesis that a change of storage
environment induces changes in the RBCs.
In the second phase, the AOP decreased because the slow-
down of glycolysis impairs the intracellular AO production
(e.g. reduction in intracellular reduced glutathione after
2 weeks). Subsequent accumulation of oxidative species
and/or re-entry of UA to protect the intracellular space
against oxidative stress [27] could explain in part the
decrease in extracellular UA concentration. Moreover, the
purine pathway is no longer active as the adenosine
monophosphate is transformed into inosine monophos-
phate, and consumed UA is not replaced [10, 11].
Finally, the time at which the AOP plateau is reached
correlates with the reactivation of the purine metabolism
(inhibition of the nucleotide salvage pathway). The feed-
ing of the glycolysis, which is a result of the pentose
phosphate pathway and the production of ribose-5 phos-
phate, produces hypoxanthine and xanthine. This process
participates partially to the in situ synthesis of UA. This
could explain why the extracellular UA concentration
and AOP did not decrease further.
As demonstrated herein, the AOP level was related to
the sex of the donor. Men had higher AOP than the
women. This global AOP does not seem to be related to a
lower haemolysis rate, although Jordan et al. reported
that the haemolysis was lower in women [26]. The
authors of that work also observed that buffy-coat pro-
cessing induces less haemolysis than whole-blood filter-
ing, suggesting that a higher amount of residual plasma
results in less haemolysis. Therefore, we might speculate
that female-derived ECs have more residual plasma and
less haemolysis. This causality might be explained by the
shift of UA following the dilution of plasma. It would be
less important in female donors and impact the RBC
metabolism less. In female donors, the capacity of RBCs
to fight against storage lesions would consequently be
better preserved. Nevertheless, this is beyond the aim of
the present study and several other parameters can also
explain the sex-dependent storability of RBCs, such as
hormones [25, 49].
The kinetics of the AOP and the extracellular concen-
tration of UA are in accordance with the three metabolic
phases previously identified [10, 11]. Notably, the kinetic
constants might demonstrate a donors’ specific release of
AOP (k1) and a consumption of UA and other AOs (k2),
depending upon the storage conditions. This loss of AO
capacity at the end of the storage corroborates the
hypothesis and the cascade of events [7, 18, 19] that
leads to the appearance of oxidative stress markers
[13, 50] and oxidized molecules [15, 17, 18].
The kinetic model could be integrated into general
kinetic analyses related to the RBC metabolism [51, 52]
and therefore be used as predictive measure for the evolu-
tion of lesions. The presented approach could be a useful
tool to understand RBC ageing and improve storage condi-
tions. It has to be noticed that this value would probably
not provide information on the quality of the RBCs and the
level of lesions as the AOP was equivalent at the beginning
and at the end of the storage. However, it could become a
very useful indicator for how changes in the storage
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solution, for example by adding AOs or by storing the sam-
ple under anaerobic conditions, can affect the AO defence
of ECs, and how this can correlate to the ageing of RBCs to
improve storage conditions.
Finally, the electrochemical method used enabled the
rapid and reliable detection of hydrophilic AOs, in partic-
ular UA, in all six EC fractions. The similarity between
total and extracellular AOP is due to the measured hydro-
philic AOs that are present in the extracellular medium.
The electrochemical measurements were performed with
small sample volumes (<3 ll) within a few seconds and
did not require any sample pretreatment, such as dilution.
This technique has the capability to be a relevant tool for
studying new storage solutions or to be considered as a
quality control test, such as in platelet concentrates [33].
Batch fabrication techniques such as screen printing or
inkjet printing allow the reproducible production of dis-
posable electrode strips and enable electrode miniaturiza-
tion [32, 53, 54]. Additionally, electrochemical
workstations (i.e. potentiostats) are nowadays available in
small and compact portable formats with wireless com-
munication. As a result, electrochemical measurements
can rapidly be performed at any location, for example in
the field, in hospitals, at bedside or at home.
The implementation of sensors prepared by alternative
advanced, large-scale production methods, such as inkjet
printing, and the application of materials with higher
activity towards the electrochemical detection of AOs, for
instance using bare carbon nanotubes (CNTs) or CNTs
covered with functional hydrogel layers [32, 55], could
offer further possibilities for the rapid, low-cost and
reliable monitoring of AOs in biological samples.
In conclusion, the AOP behaviour reflects the metabolic
activity during the first 2 weeks of storage as previously
reported [7, 10]. Our observations could be the result of
the release of UA from the RBCs. The excretion of UA
might disturb and displace the RBC metabolism through
the purine salvage pathway during the first week of stor-
age. Moreover, the sex has an impact and highlights the
necessity to consider certain donor characteristics when
evaluating the properties of the blood products and to
potentially adapt the processing. The intracellular meta-
bolism still needs to be studied in detail. Increasing the
intracellular AOP defence and potentially postponing
storage lesions could contribute to the improvement of
the quality of blood products. The correlation between
the AO levels in whole blood and in the derived ECs, and
the quality of stored RBCs will be further studied.
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